Communicable/Non Communicable Diseases
In today's globalized world, rapid urbanization, mechanization of the rural economy, and the activities of trans-national food, drink and tobacco corporations are associated with behavioral changes that increase the risk of chronic non-communicable diseases (NCDs). These changes include less healthy diet, lower physical activity, tobacco smoking and increased alcohol consumption. As a result, population health profiles are rapidly changing. For example, the global burden of type 2 diabetes mellitus is expected to double by 2030, with 80% of adult cases occurring in low and middle-income countries (LMIC). Many LMIC are undergoing rapid changes associated with developing high rates of NCD while concomitantly battling high levels of certain communicable diseases, including HIV, TB and malaria. This has population health, health systems and economic implications for these countries. This critical review synthesizes evidence on the overlap and interactions between established communicable and emerging NCD epidemics in LMIC. The review focuses on HIV, TB and malaria and explores the disease-specific interactions with prevalent NCDs in LMIC including diabetes, cardiovascular disease, chronic obstructive pulmonary disease, chronic renal disease, epilepsy and neurocognitive diseases. We highlight the complexity, bi-directionality and heterogeneity of these interactions and discuss the implications for health systems.
- Comorbidity
- Epidemologic transistion
- Ischemic heart disease
- Diarrheal disease
- Major depressive disorder
Related Conference of Communicable/Non Communicable Diseases
21st International Conference on Virology, Emerging Diseases & vaccines
10th International Conference on Microbiome, Probiotics & Gut Nutrition
9th International Conference on Antimicrobial and Antibacterial Agents
9th International Conference on Clinical Microbiology, Virology and Infectious Diseases
22nd International Conference on Microbial Interactions & Microbial Ecology
Communicable/Non Communicable Diseases Conference Speakers
Recommended Sessions
- Antimicrobial resistance & Its Consequences
- Auto immune Diseases
- Cardiac Infections
- Communicable/Non Communicable Diseases
- Emerging Infectious Disease
- Host-Pathogen Interactions
- Infection and Immunity
- Infectious Diseases, Prevention & Control
- Microbial Pathogenesis
- Postnatal infections
- Prenatal Infections
- Renal Infections
- Sexually transmitted infections
- The Pathology Of Devices
- Zika: The Next Emerging Threat?
Related Journals
Are you interested in
- Advances in Bacteriology and Microbiology - Bacteriology-2026 (UAE)
- Agricultural Microbiology & Plant–Microbe Interactions - Beneficial Microbes 2027 (UK)
- Animals in a Bacterial World-A New Imperative for the Life Sciences - Microbiome 2026 (USA)
- Antimicrobial Resistance and Antibiotic Alternatives - Bacteriology-2026 (UAE)
- Arbuscular Mycorrhizal Fungi (AMF) - Microbiome 2026 (USA)
- Bacterial and Microbial Genomics & Proteomics - Bacteriology-2026 (UAE)
- Bacterial Selection for Biological Control of Plant Disease - Microbiome 2026 (USA)
- Biofilms & Microbial Surface Interactions - Beneficial Microbes 2027 (UK)
- Bioinformatics and Microbial Data Science - Bacteriology-2026 (UAE)
- Biostimulants and Biocontrol Strategies - Microbiome 2026 (USA)
- Clinical and Neuro Virology - Virology-2026 (UK)
- Clinical Microbiology and Infectious Diseases - Bacteriology-2026 (UAE)
- Computational and AI-driven Microbiology - Bacteriology-2026 (UAE)
- Emerging infectious diseases and the "One Health" concept - Virology-2026 (UK)
- Environmental Microbiology and Bioremediation - Bacteriology-2026 (UAE)
- Epidemiology of Re-Emerging Infectious Diseases - Virology-2026 (UK)
- Extremophiles & Microbial Adaptation - Beneficial Microbes 2027 (UK)
- Food Microbiology and Safety - Bacteriology-2026 (UAE)
- General Virology - Virology-2026 (UK)
- Harnessing Phytomicrobiome Signaling for Microbiome Engineering - Microbiome 2026 (USA)
- Immunization and Immunotherapeutics - Virology-2026 (UK)
- Industrial Microbiology and Biotechnology - Bacteriology-2026 (UAE)
- Influenza and other Respiratory Diseases - Virology-2026 (UK)
- Interplay Between Diet, Gut Microbiota, Epigenetic Events and Colorectal Cancer - Microbiome 2026 (USA)
- Marine Microbiology & Microbial Resources - Beneficial Microbes 2027 (UK)
- Measles as re-emerging infectious disease - Virology-2026 (UK)
- Medical and Pharmaceutical Microbiology - Bacteriology-2026 (UAE)
- Microbial Biomanufacturing & Bioeconomy - Beneficial Microbes 2027 (UK)
- Microbial Biomaterials & Bio-Based Products - Beneficial Microbes 2027 (UK)
- Microbial Communication & Quorum Sensing - Beneficial Microbes 2027 (UK)
- Microbial Diagnostics & Advanced Detection Technologies - Beneficial Microbes 2027 (UK)
- Microbial Ecology & Community Interactions - Beneficial Microbes 2027 (UK)
- Microbial Ecology and Evolution - Bacteriology-2026 (UAE)
- Microbial Enzymes & Biocatalysis - Beneficial Microbes 2027 (UK)
- Microbial Enzymes and Metabolites - Bacteriology-2026 (UAE)
- Microbial Evolution & Adaptive Biology - Beneficial Microbes 2027 (UK)
- Microbial Fermentation & Bioprocess Development - Beneficial Microbes 2027 (UK)
- Microbial Metabolites & Bioactive Compounds - Beneficial Microbes 2027 (UK)
- Microbial Pathogenesis and Host Interactions - Bacteriology-2026 (UAE)
- Microbial Resources & Culture Collections - Beneficial Microbes 2027 (UK)
- Microbiome and Human Health - Bacteriology-2026 (UAE)
- Microbiome as a Human Organ - Microbiome 2026 (USA)
- Microbiome- Science Comes to Life - Microbiome 2026 (USA)
- Modulation of Microbiota - Microbiome 2026 (USA)
- New and Endogenous Retroviruses - Virology-2026 (UK)
- Novel Antiviral Therapies - Virology-2026 (UK)
- Novel Vaccine Delivery Methods - Virology-2026 (UK)
- One Health & Microbial Interactions - Beneficial Microbes 2027 (UK)
- Pediatric Microbiome-Vaginal Delivery vs C-Section - Microbiome 2026 (USA)
- Plant Beneficial Microbes - Microbiome 2026 (USA)
- Plant Conditioners (Biostimulants) - Microbiome 2026 (USA)
- Role of Microbial Communities in Periodontal Diseases and Caries (Oral Microbiome) - Microbiome 2026 (USA)
- Signaling in the PhytoMicrobiome - Microbiome 2026 (USA)
- Skincare Products with Probiotics-Worth the Hype? - Microbiome 2026 (USA)
- STD's and Non-Viral STIs - Virology-2026 (UK)
- Structural and Molecular virology - Virology-2026 (UK)
- Synthetic and Systems Microbiology - Bacteriology-2026 (UAE)
- The Gut Microbiota - Centerpiece of Human Health - Microbiome 2026 (USA)
- The Microbiome as a Therapeutic Target for Metabolic Diseases - Microbiome 2026 (USA)
- The Microbiome in Cancer Development and Therapy - Microbiome 2026 (USA)
- The Microbiota in Early Life Shapes the Immune System - Microbiome 2026 (USA)
- The Skin Microbiome - Microbiome 2026 (USA)
- Transmission of Viruses - Virology-2026 (UK)
- Transplant-Associated Viral Infections - Virology-2026 (UK)
- Vaccines against Emerging Diseases (Ebola/Zika/Dengue/Chik) - Virology-2026 (UK)
- Vaccines against tropical and neglected diseases - Virology-2026 (UK)
- Vaccines and the Microbiome - Virology-2026 (UK)
- Veterinary virology - Virology-2026 (UK)
- Viral Genetics, Evolution and Dynamics - Virology-2026 (UK)
- Viral Immunology and Immunopathology - Virology-2026 (UK)
- Viral Oncology - Virology-2026 (UK)
- Viral Pathogenesis - Virology-2026 (UK)

